Sanofi
Sanofi has announced two new members of its Executive Committee.
Jose Barella has decided to step down from his role as Executive Vice President Merial, and will be replaced by Carsten Hellmann (left) who joins the firm from Chr. Hansen Holding.
Secondly, Dr. David Meeker (right) – currently CEO of Genzyme - will become Executive Vice President, Genzyme.
“Carsten has gained an impressive reputation for building successful businesses. He has a wide and varied experience in life sciences, pharma and diagnostics,” said Sanofi CEO Christopher Viehbacher.
Regarding Meeker, he said:“David’s leadership is testament to his talent and passion for patients. David has a deep knowledge of the rare diseases business and has developed a deep understanding of what physicians and patients need.”